Kiromic Biopharma, Inc. Proceeds from Notes Payable
Kiromic Biopharma, Inc. reported Proceeds from Notes Payable of $900.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromNotesPayable · last filed 2025-02-14
- Kiromic Biopharma, Inc. proceeds from notes payable for the quarter ending 2024-12-31 was $500.00K.
- Kiromic Biopharma, Inc. proceeds from notes payable for the quarter ending 2024-09-30 was $0.00.
- Kiromic Biopharma, Inc. proceeds from notes payable for the quarter ending 2023-12-31 was $0.00.
- Kiromic Biopharma, Inc. proceeds from notes payable for the quarter ending 2023-09-30 was $0.00.
- Kiromic Biopharma, Inc. proceeds from notes payable for fiscal 2024 was $900.00K.
- Kiromic Biopharma, Inc. proceeds from notes payable for fiscal 2023 was $0.00.
- Kiromic Biopharma, Inc. proceeds from notes payable for fiscal 2019 was $250.00K.
| Period end | Proceeds from Notes Payable 3 month | Proceeds from Notes Payable 6 month | Proceeds from Notes Payable 9 month | Proceeds from Notes Payable 12 month |
|---|---|---|---|---|
| 2024-12-31 | $500.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $500.00K derived: sum of 2 quarters · filed 2025-02-14 | $900.00K 10-K · filed 2025-02-14 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $400.00K 10-Q · filed 2024-11-08 | ||
| 2024-06-30 | $400.00K 10-Q · filed 2024-08-09 | |||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $0.00 derived: sum of 2 quarters · filed 2025-02-14 | $0.00 10-K · filed 2025-02-14 | |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | ||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-09 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $250.00K 10-K · filed 2021-03-31 | ||
| 2019-09-30 | $250.00K 10-Q · filed 2020-11-30 |